La Monitorizzazione Della Conducibilità Elettrica Della Soluzione di dialisi

Reissmann K.R. . Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. Blood 1950; 5: 372–80.

Radtke H.W. , Clausner A. , Erbes P.M. Serum erythropoietin concentration in chronic renal failure: relationship to the degree of anemia and excretory renal function. Blood 1979; 54: 877–84.

Mc Gonigle R.J.S. , Wallin J.D. , Shadduck R.K. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int 1984; 35: 437–44.

Lin F.K. , Suggs S. , Lin C.H. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985; 82: 7580–4.

Eschbach J.W. . The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989; 35: 134–48.

Dordal M.S. , Wang F.F. , Goldwasser E. . The role of carbohydrate in erythropoietin action. Endocrinology 1985; 116: 2293–9.

Jacobs K. , Shoemaker C. , Ru-densdorf R. Isolation and characterization of genomic and c DNA clones of human erythropoietin. Nature 1985; 313: 806–9.

Recny M.A. , Scoble H.A. , Kim Y. . Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin. J Biol Chem 1987; 262: 17156–63.

Lacombe C. , Da Silva J.L. , Bru-neval P. Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest 1988; 81: 620–3.

Koury S.T. , Bondurant M.C. , Koury M.J. . Localization of erythroprotein synthesizing cells in murine kidneys by in situ hybridization. Blood 1988; 71: 524–7.

Fisher J.W. . Pharmacological modulation of erythropoietin production. Ann Rev Pharmacol Toxicol 1988; 28: 101–2.

Goldwasser E. . Erythropoietin and the differentiation of red blood cells. Fed Proc 1975; 34: 2285–92.

Wagemaker G. , Ober-Kielten-burg V.E. , Brouwer A. , Peters-Slough M.F. . Some characteristics of in vitro erythroid colony and burst-forming units. In: Exp Hematology Today, Baum S.J. , Ledeney G.D. eds. 1977; 103.

Iscove N.N. . Erythropoietin independent regulation of early erythropoiesis. Exp Hematol (abs) 1977; 6.

Sawada K. , Krantz S.B. , Kans J.S. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest 1987; 80: 357–66.

Lamperi S. , Carozzi S. , Ieardi A. , Nasini M.G. , Traverso G.B. . Cause dell'anemia nell'uremico e nuove prospettive terapeutiche. In: Attualità Nefrologiche e Dialitiche Wichtig Editore 1987; 193–200.

Icardi A. , Traverso G.B. , Paoletti E. , Cappelli G. , Molinelli G. . CAPD ed eritropoietina a basse dosi nel trattamento dell'anemia uremica. Atti del XXX Congreesso Nazionale Soc. Italiana di Nefrologia, Venezia 1989 (in stampa).

Traverso G.B. , Paoletti E. , Sarchi C. , Icardi A. . Red cell membrane during erythropoietin therapy in hemodialysis (HD) and in hemodiafiltration (HDF). Abstr XXVI ESAO Congress, Bruxelles 1989; 585.

Hughes R.T. , Cotes P.M. , Oliver D.O. Correction of the anaemia of chronic renal failure with erythropoietin: pharmacokinetic studies in patients on haemodialysis and CAPD. Contr Nephrol 1989; 76: 122–30.

Bommer J. , Ritz E. , Weinreich T. Subcutaneous erythropoietin. Lancet 1988; 1: 406.

Eschbach J.W. , Kelly M.R. , Haley N.R. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989; 321: 158–63.

Icardi A. , Paoletti E. , Traverso G.B. , Cappelli G. , Molinelli G. . Terapia con eritropoietina ricombinante umana (r-HuE-PO) nell'anemia uremica in CAPD: via sottocutanea vs via intraperitoneale. In: Dialisi Peritoneale. Buoncristiani U. ed. Atti del V Convegno Nazionale, Perugia 1989; 305–9.

Icardi A. , Paoletti E. , Molinelli G. . Efficacy of recombinant erythropoietin after s.c. and i.p. administration to patients on continuous ambulatory peritoneal dialysis (CAPD). In: Advances in Continuous Ambulatory Peritoneal Dialysis, Xth Annual CAPD Conference, Dallas 1990 (in stampa).

Icardi A. , Traverso G.B. , Cappelli G. , Paoletti E. , Molinelli G. . Trattamento a lungo termine con eritropoietina ricombinante umana nei pazienti in emodialisi periodica. In: L'e-modiafiltrazione ed i trattamenti ad alti flussi. Wichtig Editore 1989; 633–79.

Casati S. , Passerini P. , Campise M.R. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. Br Med J 1987; 295: 1017–20.

Schaefer R.M. , Leschke M. , Straver B.E. , Heidland A. . Blood rheology and hypertension in hemodialysis patients treated with erythropoietin. Am J Nephrol 1988; 8: 449–53.

Henry D.H. . Treatment of anemia in patients with AIDS. Symp Abstr Ann Am Soc Hematol, (abstr.) 1988; 3.

Nonnast-Daniel B. , Creutzig A. , Kuhn K. Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenation. Contr Nephrol 1988; 66: 185–94.

Granolleras C. , Deschoott G. , Eisenbach G. Effect of recombinant human erythropoietin (EP) on haemofiltration (HF) and haemodiafiltration (HDF). Abstract EDTA-ERA, Madrid 1988; 206.

Molinelli G. , Icardi A. , Paoletti E. , Traverso G.B. , Cappelli G. . Long-term study of erythropoietin effects in chronic hemodialysis patients. XXVI ESAO Congress, Bruxelles 1989, Int J Artif Organs (in stampa).

Steinhauer R.B. , Lubrich-Bir-kner I. , Dreyling K.W. , Schollmeyer P. . Human recombinant erythropoietin (r-hEPO) increases peritoneal ultrafiltration in CAPD patiens. Abstract EDTA Goteborg 1989; 212.

Gretz N. , Lasserre J.J. , Meisinger E. Does erythropoietin promote a loss of renal function? Abstract EDTA-ERA, Madrid 1988; 207.

Icardi A. , Di Maio G. , Traverso G.B. , Lamperi D. , Paoletti E. , Molinelli G. . Effetti della eritropoietina ricombinante umana (r-HuEPO) nel trattamento dell'anemia uremica in pazienti in fase pre dialitica ed in emodialisi. Abstr 4^a Riunione Congiunta Soc. de Nephrologie, Soc. Espanda de Nefrologia, Soc. Italiana di Nefrologia, Torino 1989; 112.